documents: FDA-2013-D-1464-0016
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-D-1464-0016 | FDA | FDA-2013-D-1464 | Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2021-08-23T04:00:00Z | 2021 | 8 | 2021-08-23T04:00:00Z | 2021-10-23T03:59:59Z | 2021-09-09T01:00:34Z | 2021-18073 | 0 | 0 | 0900006484c9bd68 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref